Trending Stock News

Ensign Group (ENSG) Holder Granahan Investment Management Increased Holding; Johnson & Johnson (JNJ) Holder Holowesko Partners LTD Decreased Stake

Granahan Investment Management Inc increased its stake in Ensign Group (ENSG) by 28.44% based on its latest 2017Q3 regulatory filing with the SEC. Granahan Investment Management Inc bought 33,051 shares as the company’s stock rose 2.87% with the market. The hedge fund held 149,261 shares of the health care company at the end of 2017Q3, valued at $3.37M, up from 116,210 at the end of the previous reported quarter. Granahan Investment Management Inc who had been investing in Ensign Group for a number of months, seems to be bullish on the $1.20 billion market cap company. The stock decreased 0.51% or $0.12 during the last trading session, reaching $23.38. About 31,267 shares traded. The Ensign Group, Inc. (NASDAQ:ENSG) has declined 7.08% since January 18, 2017 and is downtrending. It has underperformed by 23.78% the S&P500.

Holowesko Partners Ltd decreased its stake in Johnson & Johnson (JNJ) by 30.91% based on its latest 2017Q3 regulatory filing with the SEC. Holowesko Partners Ltd sold 131,500 shares as the company’s stock rose 6.85% with the market. The hedge fund held 293,900 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $38.21M, down from 425,400 at the end of the previous reported quarter. Holowesko Partners Ltd who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $392.45 billion market cap company. The stock decreased 0.61% or $0.9 during the last trading session, reaching $146.08. About 1.60M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 18, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Since August 2, 2017, it had 0 insider purchases, and 11 selling transactions for $870,657 activity. Port Barry sold 177 shares worth $3,698. The insider Snapper Suzanne D. sold $10,353. Wittekind Beverly B. also sold $2,298 worth of The Ensign Group, Inc. (NASDAQ:ENSG) shares. 332 shares were sold by Keetch Chad, worth $6,937 on Tuesday, September 5.

Granahan Investment Management Inc, which manages about $3.81B and $1.20B US Long portfolio, decreased its stake in Affiliated Managers Group (NYSE:AMG) by 77,028 shares to 22 shares, valued at $4,000 in 2017Q3, according to the filing. It also reduced its holding in Enanta Pharmaceuticals (NASDAQ:ENTA) by 49,654 shares in the quarter, leaving it with 102,041 shares, and cut its stake in Veeva Systems (NYSE:VEEV).

Among 7 analysts covering Ensign Group (NASDAQ:ENSG), 4 have Buy rating, 1 Sell and 2 Hold. Therefore 57% are positive. Ensign Group had 16 analyst reports since August 5, 2015 according to SRatingsIntel. The stock has “Mkt Underperform” rating by JMP Securities on Wednesday, January 4. The company was maintained on Monday, July 31 by RBC Capital Markets. As per Friday, September 1, the company rating was maintained by RBC Capital Markets. Wells Fargo downgraded the stock to “Market Perform” rating in Thursday, May 12 report. The company was maintained on Sunday, November 19 by RBC Capital Markets. On Wednesday, August 5 the stock rating was maintained by Oppenheimer with “Outperform”. The stock of The Ensign Group, Inc. (NASDAQ:ENSG) earned “Buy” rating by Oppenheimer on Thursday, August 3. The firm has “Buy” rating given on Thursday, August 4 by SunTrust. The stock has “Buy” rating by RBC Capital Markets on Monday, June 26. Cantor Fitzgerald maintained The Ensign Group, Inc. (NASDAQ:ENSG) rating on Thursday, November 9. Cantor Fitzgerald has “Buy” rating and $27.0 target.

Investors sentiment decreased to 1.11 in 2017 Q3. Its down 0.45, from 1.56 in 2017Q2. It dived, as 10 investors sold ENSG shares while 47 reduced holdings. 20 funds opened positions while 43 raised stakes. 41.50 million shares or 1.56% more from 40.87 million shares in 2017Q2 were reported. Aperio Grp Inc Ltd Llc, a California-based fund reported 14,377 shares. Deutsche Bancorp Ag reported 0% of its portfolio in The Ensign Group, Inc. (NASDAQ:ENSG). Btim holds 0.17% or 487,436 shares. Granahan Investment Mngmt Ma invested in 0.28% or 149,261 shares. Comml Bank Of The West invested in 0.06% or 19,463 shares. South Dakota Invest Council invested in 64,800 shares. Metropolitan Life Insur Com Ny stated it has 34,058 shares. Legal General Gp Public Limited Com reported 92,837 shares. Heartland stated it has 300,000 shares or 0.44% of all its holdings. Scotia Cap reported 0% in The Ensign Group, Inc. (NASDAQ:ENSG). 83,429 were reported by Goldman Sachs Inc. Wasatch invested 2.02% of its portfolio in The Ensign Group, Inc. (NASDAQ:ENSG). Citigroup Inc holds 0% or 36,587 shares in its portfolio. Kestrel Inv Mngmt Corporation has invested 2.79% in The Ensign Group, Inc. (NASDAQ:ENSG). Wells Fargo & Company Mn invested in 0% or 205,707 shares.

Holowesko Partners Ltd, which manages about $4.09 billion and $1.26B US Long portfolio, upped its stake in Gilead Sciences Inc (NASDAQ:GILD) by 13,000 shares to 1.22M shares, valued at $98.68M in 2017Q3, according to the filing. It also increased its holding in Nvidia Corp (Put) (NASDAQ:NVDA) by 55,000 shares in the quarter, for a total of 165,000 shares, and has risen its stake in China Mobile Limited (NYSE:CHL).

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It is flat, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Auxier Asset holds 102,851 shares or 2.72% of its portfolio. First Heartland Consultants holds 0.64% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 20,100 shares. Advisory Svcs Network Ltd Limited Liability Company holds 0.73% in Johnson & Johnson (NYSE:JNJ) or 48,832 shares. Utd Asset Strategies accumulated 0.41% or 5,574 shares. Willow Creek Wealth Mngmt stated it has 12,136 shares. Perkins Coie Tru reported 7,444 shares. Truepoint Incorporated stated it has 0.02% in Johnson & Johnson (NYSE:JNJ). Community Bank & Trust Of Raymore invested in 0.48% or 8,700 shares. Bonness Inc owns 41,038 shares. Gillespie Robinson Grimm owns 230,510 shares. Mason Street Advisors Ltd Co stated it has 372,589 shares or 1.19% of all its holdings. Ig Investment Management Limited holds 1.87 million shares or 1.25% of its portfolio. Princeton Portfolio Strategies Gp Ltd Liability Corporation holds 3.23% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 91,726 shares. Eagle Global Advisors Ltd Llc owns 76,347 shares or 0.3% of their US portfolio. The California-based Advisor Llc has invested 1.6% in Johnson & Johnson (NYSE:JNJ).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 86 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Thursday, August 4 with “Hold”. On Tuesday, December 1 the stock rating was upgraded by Barclays Capital to “Overweight”. As per Friday, October 6, the company rating was maintained by Cowen & Co. As per Monday, September 25, the company rating was initiated by Citigroup. As per Wednesday, October 18, the company rating was maintained by Argus Research. The firm earned “Buy” rating on Monday, July 10 by RBC Capital Markets. The firm earned “Equal-Weight” rating on Wednesday, October 18 by Morgan Stanley. The firm has “Buy” rating given on Tuesday, October 17 by BMO Capital Markets. The firm has “Buy” rating by Wells Fargo given on Wednesday, October 18. The firm has “Outperform” rating given on Tuesday, August 25 by Cowen & Co.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 earnings per share, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62 billion for 21.23 P/E if the $1.72 EPS becomes a reality. After $1.90 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *